ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven by positive clinical trial data for its CKD treatment.
ProKidney (PROK) Shares Skyrocket On Promising Kidney Disease Drug Trial Results
